Putting The E In ESG: A Global Medtech’s Approach To Meeting The Climate Challenge
Patient Safety The Priority As Medtechs Face Growing Compliance Requirements
Executive Summary
The pressures on global medtechs to focus more on sustainability are internal as well as external. Scope 3 adds yet another layer of compliance. Johnson & Johnson’s EMEA VP for Surgical Vision Erin McEachren explains to In Vivo how her organization meets these challenges while simultaneously addressing EU Medical Device Regulation requirements and ensuring patient safety standards.
You may also be interested in...
The E in ESG: Beware Green Claims That Might Backfire
Health care companies making carbon neutrality claims must tread a careful line while ensuring full accountability. CMS Vienna partner Gabriela Staber points to some of the risks businesses should be aware of when making sustainability claims.
The E In ESG: Does PVC Have A Future In Health Care’s Circular Economy?
PVC, the most used polymer in the manufacture of single-use medical devices, has always been a target for the environmental lobby. The rise of the green agenda has heightened sensitivities further still. Europe’s PVC MedAlliance aims to show how the substance can fit into sustainability programs.
Putting The E In ESG: The Provider’s View Of Sustainability Compliance
As the health care sector moves from linear to circular, medtechs, providers and patients all have roles to play in ensuring that current strategies, practices and behaviors contribute to guarantee a sustainable future. Part one of a short series on this theme looks as best practice for providers.